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NGFcontrols survival, differentiation, and target
innervation of both peptidergic and nonpepti-
dergic DRG sensory neurons. The common re-
ceptor for GDNF family ligands, Ret, is highly
expressed in nonpeptidergic neurons, but its
function during development of these neurons
is unclear. Here, we show that expression of
Ret and its coreceptors GFRa1 and GFRa2 is
dependent on NGF. GFR/Ret signaling, in turn,
autoregulates expression of both GFRa1 and
GFRa2 and promotes expression of TrpA1,
MrgA1, MrgA3, and MrgB4, acquisition of nor-
mal neuronal size, axonal innervation of the
epidermis, and postnatal extinction of the NGF
receptor TrkA. Moreover, NGF controls expres-
sion of several other genes characteristic of
nonpeptidergic neurons, such asTrpC3,TrpM8,
MrgD, and the transcription factor Runx1, via
a Ret-independent signaling pathway. These
findings support a model in which NGF controls
maturation of nonpeptidergic DRG neurons
through a combination of GFR/Ret-dependent
and -independent signaling pathways.
INTRODUCTION
Sensory neurons of the dorsal root ganglia (DRG) detect
information in the periphery and convey it to the central
nervous system. DRG neurons are greatly diversified with
respect to both morphological and physiological proper-
ties. Subsets of these neurons respond to tactile, thermal,
proprioceptive, and nociceptive stimuli and are classified
as mechanoreceptors, thermoceptors, proprioceptors,
and nociceptors, respectively. In addition to detecting
distinct sensory modalities, each population expresses aunique array of molecular markers, including ion channels
and receptors for specific neurotrophic growth factors.
A central question in sensory neurobiology is how such
remarkable diversity of primary somatosensory neurons
is achieved during development.
There are two main populations of cutaneous nocicep-
tors in adult mice (Molliver et al., 1995; Priestley et al.,
2002). One population expresses the tyrosine kinase Ret,
the signaling receptor for the glial-derived neurotrophic
factor (GDNF) family ligands (GFLs), and comprises ap-
proximately 60% of total DRG neurons. The other, smaller
population expresses TrkA, the receptor for nerve growth
factor (NGF). Mature TrkA+ neurons express the neuro-
peptide calcitonin gene-related peptide (CGRP) and are
accordingly termed peptidergic nociceptors. Ret+ neu-
rons, in contrast, are called nonpeptidergic nociceptors
and are characterized by their ability to bind to the lectin
Griffonia simplicifolia IB4. These two populations exhibit
distinct patterns of peripheral and central axonal projec-
tions. The peripheral axons of TrkA+ peptidergic neurons
terminate in the stratum spinosum (SS) of glabrous skin
while their central axonal projections terminate in lamina
I and outer lamina II (IIo) of the dorsal horn of the spinal
cord. Peripheral projections of Ret+ nonpeptidergic neu-
rons, in contrast, terminate in the superficial stratum gran-
ulosum (SG) of the epidermis, while their central axonal
projections end in inner lamina II (IIi) of the spinal cord
(see Figure S2A in the Supplemental Data available with
this article online; Zylka et al., 2005).
DRG neurons arise from neural crest precursors which,
in the mouse, coalesce into ganglia beginning around
E9.5. Shortly after neurogenesis, most DRG neurons initi-
ate expression of TrkA and become responsive to NGF
(White et al., 1996). A distinct but small population of
TrkA DRG neurons expresses Ret as early as E12; these
TrkA/Ret+ neurons are classified as the early Ret popula-
tion (Molliver et al., 1997). The vast majority of Ret+ neu-
rons, however, emerge from TrkA+ neurons during the late
embryonic period. These neurons begin to express Ret
around E16 and gradually extinguish expression of TrkANeuron 54, 739–754, June 7, 2007 ª2007 Elsevier Inc. 739
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Thus, although TrkA is expressed in most DRG neurons
during embryonic development, only a subset of them,
mainly CGRP+ peptidergic neurons, continue to express
TrkA into adulthood. The segregation of TrkA+ and Ret+
neuronal populations is complete between 2 and 3 weeks
after birth.
What are the factors that control the differentiation and
segregation of TrkA+ and Ret+ nociceptors? Neurotrophic
factors, including NGF, BDNF, and NT-3, along with their
cognate receptors, are critical for survival, differentiation,
and peripheral target innervation of distinct classes of
DRG sensory neurons (Marmigere and Ernfors, 2007). A
well-documented example is the dependence of nocicep-
tor development on NGF-TrkA signaling (Crowley et al.,
1994; Levi-Montalcini, 1987). The transition of nonpepti-
dergic neurons from TrkA+ to Ret+ suggests that these
neurons switch their dependence from TrkA signaling to
Ret signaling during postnatal periods (Molliver et al.,
1997). However, whether Ret signaling controls differenti-
ation, survival or other aspects of development of nonpep-
tidergic neurons remains unclear mainly because Ret null
mice die shortly after birth due to renal agenesis, prior to
final maturation of these neurons.
The GDNF family of ligands (GFLs) contains four mem-
bers, GDNF (Lin et al., 1993), neurturin (NRTN; Kotzbauer
et al., 1996), artemin (ARTN; Baloh et al., 1998), and perse-
phin (PSPN; Milbrandt et al., 1998). Each GFL signals
through a receptor complex containing the signaling sub-
unit Ret and one member of a family of GPI-linked pro-
teins, the GFL receptors (GFRs). There are four GFRs
in vertebrates, designated GFRa1 through GFRa4. In vitro
binding assays indicate that GDNF binds preferentially to
GFRa1 (Jing et al., 1996; Treanor et al., 1996; Trupp et al.,
1996), NRTN to GFRa2 (Buj-Bello et al., 1997; Klein et al.,
1997), ARTN to GFRa3 (Baloh et al., 1998), and PSPN to
GFRa4 (Enokido et al., 1998). GFRa1, GFRa2, GFRa3,
but not GFRa4 are expressed in DRG neurons. There are
inconsistencies among the reported DRG phenotypes of
the various GFL and GFR null mice (Cacalano et al.,
1998; Enomoto et al., 1998; Honma et al., 2002; Lindfors
et al., 2006; Moore et al., 1996; Nishino et al., 1999; Rossi
et al., 1999), which are potentially explained by either re-
dundant roles of GFRs and/or GFLs or unpredicted
GFL-GFR interactions in vivo. Thus, conditional ablation
of Ret in sensory neurons is required to establish the func-
tions of GFL-GFR/Ret signaling in development of non-
peptidergic sensory neurons in vivo.
In addition to neurotrophic growth factors, several tran-
scription factors are implicated in the control of nociceptor
differentiation (Marmigere and Ernfors, 2007). Neurogenin
1 (Ngn1) and Neurogenin 2 (Ngn2) are required soon after
DRG formation for the generation of sensory neurons, in-
cluding nociceptors (Ma et al., 1998, 1999). The Runt do-
main transcription factorRunx1 is also critical for nocicep-
tor differentiation (Chen et al., 2006; Kramer et al., 2006b;
Yoshikawa et al., 2007). Runx1 is essential for expression
of Ret, certain Mrg and Trp genes, and other genes char-740 Neuron 54, 739–754, June 7, 2007 ª2007 Elsevier Inc.acteristic of Ret+ nonpeptidergic nociceptors. However,
the identity of upstream factors that regulate Runx1 and
other genes that define the molecular, morphological, and
functional properties of Ret+ nociceptors are unknown.
Here, we report that NGF regulates expression of GFRs
and Ret, instructing a subset of TrkA+ sensory neurons to
adopt the nonpeptidergic sensory neuron fate. We show
that Ret signaling is critical for acquisition of several fea-
tures of the nonpeptidergic neuronal phenotype, including
expression of a subset of Trp and Mrg genes, innervation
of the epidermis, control of normal neuronal size, and
postnatal extinction of TrkA. Interestingly, expression of
some other Trp and Mrg genes, also characteristic of
Ret+ nociceptors, is independent of Ret signaling. Instead,
NGF controls their expression, possibly through regula-
tion of Runx1. Our findings support a model in which
NGF promotes differentiation and maturation of nonpepti-
dergic neurons through both Ret-dependent and Ret-in-
dependent signaling mechanisms.
RESULTS
Developmental Transition of Nonpeptidergic
DRG Neurons from TrkA+ to Ret+
To examine the process of differentiation of DRG nocicep-
tor neurons and, in particular, the emergence of Ret+ non-
peptidergic nociceptors from TrkA+ precursors, we first
performed double fluorescent in situ hybridization onwild-
type mouse DRGs at embryonic day 12 (E12), E16, post-
natal day 0 (P0), P5, P10, and P14 using cRNA probes
against TrkA and Ret (Figure 1A). TrkA expression is read-
ily detected in the majority of DRG neurons at E12. In con-
trast, expression of Ret is observed in only a few neurons
at E12, attributable to the previously described early Ret+
neuronal population (Molliver et al., 1997). These early
Ret+ neurons have large-diameter soma and do not coex-
press TrkA (Figure 1A). Many TrkA+ neurons, however, be-
gin to coexpress Ret at E16 (Figure 1A). These small to
medium diameter Ret+ neurons are the late Ret+ popula-
tion destined to become nonpeptidergic nociceptors,
which constitute more than 90% of the total Ret+ DRG
neurons of the adult mouse. These Ret+/TrkA+ neurons
undergo a phase of TrkA extinction, which begins postna-
tally and is not complete until P14 (Figure 1A). Our in situ
hybridization findings are consistent with previous obser-
vations (Molliver and Snider, 1997; Molliver et al., 1997)
and suggest that nonpeptidergic nociceptors undergo
a transition from dependence on NGF-TrkA signaling to
GFL-GFR/Ret signaling.
GFRa2 Is the Predominant Coreceptor
Expressed in Ret+ DRG Neurons
Despite previous reports describing the expression of
GFRa1, GFRa2, and GFRa3 in DRG neurons, the relative
importance of GFR coreceptors for Ret signaling in DRGs
is unknown (Fundin et al., 1999). We performed double
fluorescent in situ hybridization analysis of DRGs at P14
using cRNA probes directed against each of the GFRs
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Neurons from TrkA+ Precursors
(A) Widespread neuronal expression of TrkA
(red) is observed in DRGs at E12. In addition,
there is a small population of Ret+ (green)/
TrkA– neurons at this time point; these are de-
fined as the early Ret population. From E16 to
P0, many TrkA+ neurons coexpress Ret. The
expression of TrkA is extinguished in Ret+ neu-
rons after birth (P5 and P10), and the segrega-
tion of TrkA+/Ret– and TrkA–/Ret+ populations
is nearly complete by P14.
(B–D) Coexpression of GFRa1, GFRa2, and
GFRa3 (red) with Ret (green) in DRG neurons
at P14. The degrees of overlap between
GFRa1, GFRa2, and GFRa3 and Ret are
18.2% ± 5.5%, 61.4% ± 6.9%, and 13.9% ±
4.0% of cells, respectively. Arrowheads point
to examples of neurons expressing both Ret
and a GFR. Note that GFRa2-positive neurons
strongly express Ret, while GFRa1- and
GFRa3-positive neurons weakly express Ret.
(E) Coexpression of all three GFRs (red) with
Ret (green) in DRG neurons at P14. The extent
of overlap between all GFRs and Ret is 99% ±
2% (n = 2, n is the number of animals; multiple
DRG sections [four to eight] were examined for
each animal). Scale bars, 20 mm.and Ret. GFRa1 is expressed in 18.2% ± 5.5%, GFRa2 in
61.4% ± 6.9%, and GFRa3 in 13.9% ± 4.0% of Ret+ neu-
rons (Figures 1B–1D). We also performed similar analysis
with probes against all GFRs and Ret and found the de-
gree of overlap to be 99% ± 2% (Figure 1E). Together,these results suggest that the overlap of expression of
different GFRs, if any, is minimum at P14.
Interestingly, while virtually allGFRa2+ neurons strongly
coexpress Ret, many of theGFRa1+ andGFRa3+ neurons
weakly coexpress Ret. Also, expression of GFRa2 in DRGNeuron 54, 739–754, June 7, 2007 ª2007 Elsevier Inc. 741
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which is temporally coincident with extinction of TrkA in
nonpeptidergic neurons. In addition, unlike GFRa2/
mice, neither GFRa1/ nor GFRa3/ mice show any
deficits in DRG neurons (Cacalano et al., 1998; Lindfors
et al., 2006; Nishino et al., 1999). These findings indicate
that GFRa2 is the predominant coreceptor of Ret in post-
natal DRG sensory neurons.
NGF Controls Expression of Ret and Its Coreceptors
NGF/;Bax/ mice have proven to be valuable tools to
study survival-independent functions of NGF (Patel et al.,
2000).While nearly all embryonic TrkA+ neurons inNGF/
mice die by apoptosis, these neurons in NGF/;Bax/
mice survive in the absence of NGF due to the concomi-
tant loss of the proapoptotic gene Bax. TrkA+ neurons are,
however, hypotrophic in this double-mutant mouse line.
The TrkA– neurons in NGF/;Bax/ mice, on the other
hand, appear normal. Since the majority of Ret+ nocicep-
tors emerge from immature TrkA+ neurons, we sought to
determine whether NGF controls expression of Ret and
its GFR coreceptors in these neurons. To address this
possibility, we compared the expression of Ret, GFRa1,
GFRa2, and GFRa3 in P0 DRGs from NGF/;Bax/
mice and NGF+/;Bax/ control mice. Since NGF/;
Bax/ mice die shortly after birth, our analysis was re-
stricted to this time point. In agreement with a previous
report (Patel et al., 2000), Ret expression is dramatically
reduced in NGF/;Bax/ DRGs; there are only a few
strongly Ret+ neurons of normal soma size in double-
mutant mice (Figures 2A and 2B). These few remaining
Ret+ neurons belong to the early Ret+ population because
they do not coexpress TrkA (Figures S2B and S2C). In ad-
dition, expression ofGFRa1 is undetectable in DRGs from
NGF/;Bax/ mice (Figures 2C and 2D). Moreover, al-
though expression of GFRa2 is normally weak at P0 and
increases postnatally in control mice, a dramatic reduction
in expression of this receptor in DRGs of NGF/;Bax/
mice was observed (Figures 2E and 2F). GFRa3, on the
other hand, does not appear to be regulated by NGF, de-
spite its expression in hypotrophic neurons of NGF/;
Bax/ mice (Figures 2G and 2H). Cell culture and
RT-PCR were also done to ask whether NGF directly
stimulates expression of Ret and its GFR coreceptors in
sensory neurons. In agreement with the in vivo results,
NGF was found to induce expression of Ret, GFRa1,
GFRa2, but not GFRa3 in cultured sensory neurons (Fig-
ures 2I and 2J). These observations, taken together, indi-
cate that NGF controls expression of both Ret and its
coreceptors, GFRa1 and GFRa2, in nonpeptidergic noci-
ceptor neurons.
Ret Conditional Knockout Mice
The roles of Ret signaling in sensory neurons have been
difficult to discern due, at least in part, to the perinatal
lethality of Ret null mice (Schuchardt et al., 1994). To over-
come this obstacle, and to examine the influence of Ret
signaling pathways on postnatal development of nonpep-742 Neuron 54, 739–754, June 7, 2007 ª2007 Elsevier Inc.tidergic sensory neurons, mice carrying a LoxP-based
conditional Ret allele were generated (see Experimental
Procedures and Figure S3A). Mice harboring the condi-
tional Ret allele (Retf/f) were crossed with mice carrying
aWnt1-Cre transgene (Chai et al., 2000), which directs ex-
pression of Cre recombinase in premigratory neural crest
cells, including all progenitors of DRG neurons. Mice het-
erozygous for both the floxed Ret allele and theWnt1-Cre
allele (Retf/+;Wnt1-Cre mice) are viable and fertile and
exhibit no obvious deficits. Importantly, Ret expression
is undetectable in DRG neurons in Retf/f;Wnt1-Cre mice
(Figures 3A and 3B), indicating efficient Cre-mediated ex-
cision of the floxed Ret allele. The exquisite specificity of
Cre-mediated recombination is shown by the unperturbed
expression of Ret in motor neurons in the ventral horn of
the spinal cord (Figures 3A and 3B). In keeping with Cre
expression in the neural crest, we also observed complete
loss of Ret expression in the myenteric plexi and sympa-
thetic ganglia of Retf/f;Wnt1-Cre mice (Figures S3C and
S3D and data not shown). Grossly, Retf/f;Wnt1-Cre mice
are indistinguishable from their littermates at birth. How-
ever, within 3 days of birth, these mice show abdominal
distension, progressive weakness, and few survive be-
yond 3 weeks of age (Figure S3B). Examination of Retf/f;
Wnt1-Cre mice as late as P14 reveals that they have an
enlarged jejunum, ileum, and colon, suggesting that they
may have intestinal aganglionosis similar to human pa-
tients carrying Retmutations who develop Hirschsprung’s
disease (data not shown). To further characterize this phe-
notype, the small intestine and colonic wall were isolated
from mutant mice and whole-mount acetylcholinesterase
histochemistry was performed to visualize enteric neu-
rons. In agreement with previous findings that Ret is re-
quired for migration and survival of enteric neurons (Natar-
ajan et al., 2002), a complete loss of enteric neurons in
both the small intestine and colon of Retf/f;Wnt1-Cremice
was observed (Figures S3E and S3F). Retf/f;Wnt1-Cre
mice are therefore a useful animal model to address the
embryonic and postnatal functions of Ret signaling in sen-
sory, sympathetic, and enteric neurons in vivo.
Ret Is Not Required for Cell Viability but Is Required
for Control of Neuronal Soma Size of Nonpeptidergic
DRG Neurons
Initial analysis of DRGs fromRetf/f;Wnt1-Cremice revealed
that they are similar in size to those of Retf/f control litter-
mates at P0 but are approximately 30% smaller at P14
(Figures S4A–S4D). We considered whether either neuro-
nal lossor hypotrophy is responsible for this phenotypebe-
cause these phenomena have been reported in GDNF/
and GFRa2/ mice, respectively (Lindfors et al., 2006;
Moore et al., 1996).
To ask if cell viability is compromised in the absence of
Ret signaling, we performed Nissl staining and cell count-
ing on whole L5 DRGs from P14 Retf/f and Retf/f;Wnt1-Cre
mice. On average, mutant L5 DRGs yielded 30% fewer
sections compared to controls (55 ± 4 sections in mutants
versus 80 ± 4 sections in controls, n = 3). Our initial
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Ret and GFRs in DRG Neurons
(A and B) Expression of Ret in NGF+/;Bax/
and NGF/;Bax/ DRGs at P0. Note that
both the number of Ret+ cells (from 62.4% ±
3.4% to 30.5% ± 2.1%) and the level of Ret
expression are greatly reduced in NGF/;
Bax/ DRGs. The remaining strongly Ret+
neurons are of the early Ret+ population be-
cause they do not coexpress TrkA (Figures
S2B and S2C).
(C–H) Expression of GFRa1, GFRa2, and
GFRa3 in NGF+/;Bax/ and NGF/;Bax/
DRGs. Expression of GFRa1 is completely
eliminated (12.2% ± 1.8% to 0%), whereas ex-
pression of GFRa2 is reduced (17.8% ± 1.3%
to 9.0% ± 1.6%), and expression of GFRa3 is
unchanged (35.2% ± 3.5% to 34.1% ± 2.3%)
in the absence NGF. Similar results were found
in each of six to eight sections from two ani-
mals of each genotype. Scale bar, 40 mm.
(I) RT-PCR analysis of Ret andGFR expression
in cultured DRG neurons grown for 48 hr in
the presence or absence of NGF. Expression
of the panneuronal marker PGP9.5 serves as
a control.
(J) Quantitation of RT-PCR reactions shows
that expression of Ret (4.7 ± 0.9-fold), GFRa1
(2.1 ± 0.1-fold), and GFRa2 (1.7 ± 0.1-fold,)
but not GFRa3 (1.1 ± 0.2-fold), are induced
by NGF.
Shown are means ± SEM.analysis revealed a 17.6%deficit in the number of neurons
in Retf/f;Wnt1-Cre mice compared to Retf/f animals (Fig-
ure 3K). However, when cell counts of dissociated DRG
neurons were performed, no significant difference in neu-
ronal numbers between DRGs from Retf/f and Retf/f;Wnt1-
Cremice was found (95.6%± 2.5%of control). In addition,
active caspase-3-positive neurons were not observed at
P10 in either mutant or control DRGs in vivo, suggesting
neuronal viability is not affected in the absence of Ret
postnatally (Figures S4E and S4F). Furthermore, the distri-
bution of several marker genes expressed in peptidergic
nociceptors (CGRP), nonpeptidergic nociceptors (P2X3)
and mechanoreceptors (NF200) was analyzed. We rea-
soned that loss of nonpeptidergic neurons should be re-flected by a higher proportion of CGRP+ neurons and a
lower proportion of P2X3+ neurons in DRGs of Retf/f;
Wnt1-Cre mice. In fact, the proportions of these markers
are nearly identical for DRGs from control and Retf/f;
Wnt1-Cremice at P14 (Figure 3O). These findings together
argue against the possibility of loss of nonpeptidergic neu-
rons in Retf/f;Wnt1-Cre DRGs.
To investigate the possibility of neuronal hypotrophy in
Retf/f;Wnt1-Cre DRGs, immunohistochemistry and cell
size analysis of peripherin+, CGRP+, and neurofilament
200+ DRG neurons was performed. Peripherin is a neurofi-
lament-associated protein expressed selectively in most
small- and medium-diameter DRG neurons, including
both peptidergic and nonpeptidergic cutaneous neurons.Neuron 54, 739–754, June 7, 2007 ª2007 Elsevier Inc. 743
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(A and B) Loss of Ret expression in sensory neurons but not motor neurons (white arrowheads) of P0 Retf/f;Wnt1-Cremice (n = 3). Scale bar, 100 mm.
(C and D) Peripherin immunostaining in DRGs of Retf/f and Retf/f;Wnt1-Cre animals at P14. Note the hypotrophic neuronal soma of most peripherin+
neurons in the mutant animal.
(E and F) Neurofilament-200 immunostaining of DRG neurons demonstrates that large diameter neurons have normal cell size in the absence of Ret.
(G and H) CGRP immunostaining in the Retf/f and Retf/f;Wnt1-Cre mouse DRGs shows comparable cell sizes in control and mutant animals.
(I and J) Double-immunofluorescent staining of P2X3 (red) and peripherin (green) (n = 3). Scale bar, 20 mm. Similar numbers of double-positive neurons
are observed in control and mutant animal DRGs. However, double-labeled neurons have a significantly smaller soma size in the mutant DRGs
compared to control animals (see arrowheads, inset). Inset scale bar, 20 mm.
(K) Cell counts observed by Nissl staining and whole-cell counting. Total neuronal profiles scored were from L5 DRGs of pooled P10 (n = 1) and
P14 animals (n = 3) for each condition. For Retf/f animals, a total of 17,312 ±1,423 neurons per L5 DRG and for Retf/f;Wnt1-Cre animals a total of
14,265 ± 941 neurons per L5 DRG were scored.
(L–N) Cell size histograms displaying the distribution of mean soma area for neurons labeled with peripherin (L), neurofilament-200 (M), and CGRP (N).
(O) The relative ratios of neurofilament 200, peripherin, CGRP, and P2X3 positive neurons per DRG normalized against PGP9.5+ DRG neurons inRetf/f
and Retf/f;Wnt1-Cre mice.
Shown are means ± SEM.744 Neuron 54, 739–754, June 7, 2007 ª2007 Elsevier Inc.
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mice are significantly smaller (47.3% reduction in soma
area) compared to those in control Retf/f mice (Figures
3C, 3D, and 3L). This reflects hypotrophy only in nonpep-
tidergic neurons because the soma sizes of CGRP+ pepti-
dergic neurons are similar in Retf/f;Wnt1-Cre and control
mice (Figures 3G, 3H, and 3N). Moreover, neurofilament
200 (NF200)-positive neurons, which are large-diameter
proprioceptive neurons, have comparable soma sizes in
mutants and controls (Figures 3E, 3F, and 3M). Finally,
double-fluorescent immunostaining for peripherin and
P2X3 was performed. Neurons labeled with both markers
are mostly nonpeptidergic neurons, and these neurons
clearly have smaller soma sizes in Retf/f;Wnt1-Cre mice
compared to controls (Figures 3I and 3J, see inset).
Thus, the absence of Ret signaling leads to hypotrophy
of nonpeptidergic nociceptors, whereas peptidergic noci-
ceptors and proprioceptive neurons are unaffected.
Taken together, these finding indicate that Ret signaling
is required for the acquisition of normal soma size but
not survival of nonpeptidergic DRG nociceptors.
Loss of Ret Signaling Influences Peripheral
but Not Central Projections of Nonpeptidergic
Sensory Neurons
We next examined the nature of peripheral and central
axonal projections inRetf/f;Wnt1-Cremice. For these anal-
yses, we used anMrgD-EGFP reporter mouse line, which
has been previously shown to express GFP in most, if
not all, nonpeptidergic nociceptive fibers innervating the
epidermis (Zylka et al, 2005). We crossed the Retf/f mice
to this MrgD-EGFP mouse line to obtain Retf/f;MrgD-
EGFP control and Retf/f;Wnt1-Cre;MrgD-EGFP mutant
mice.Asexpected,GFP+fibers are abundant in theepider-
mis ofRetf/f;MrgD-EGFP controlmice,with free nerve end-
ings terminating in the stratum granulosum. CGRP+ fibers,
on the other hand, were foundmostly restricted to the sub-
epidermal layer, with a few free nerve endings coursing
through the epidermis and terminating in the stratum spi-
nosum (Figures 4A, 4C, 4E, and 4G). In the Retf/f;Wnt1-
Cre;MrgD-EGFP mutant mice, although the CGRP+
innervation to the epidermis was present, there was a
substantial reduction in the number of GFP+ nonpeptider-
gic fibers innervating the epidermis (Figure 4K). Further-
more, the few remaining GFP+ fibers in the epidermis of
mutant mice were weakly stained in a punctate manner
(Figures 4B, 4D, 4F, and 4H). In complementary experi-
ments, we employed PGP9.5 and CGRP to label nonpep-
tidergic sensory fibers by exclusion (Lindfors et al., 2006)
and found a similar phenotype (Figure S5). The lack of
nonpeptidergic epidermal fibers in Retf/f;Wnt1-Cre mice,
found by these two methods, could be caused by a failure
of epidermal innervation, axonal retraction, severe axonal
hypotrophy, or a combination of the above.
To examine whether central projections of nonpeptider-
gic neurons are affected by the absence of Ret function,
we performed CGRP and GFP double immunostaining
on spinal cord sections from Retf/f;MrgD-EGFP and Retf/f;Wnt1-Cre;MrgD-EGFP mice. Central projections of both
CGRP+ and GFP+ neurons formed distinct layers, and the
lamina-specific innervation of nonpeptidergic neurons is
unperturbed in Retf/f;Wnt1-Cre;MrgD-EGFPmice (Figures
4I, 4J, and 4L). Thus, Ret signaling is essential for cutane-
ous peripheral projections of nonpeptidergic neurons,
but it is not required for the integrity of their central
projections.
Ret Signaling Controls Expression of Its Coreceptors
Although a 45% reduction of GFRa2+ neurons was re-
ported inNRTN/ DRGs (Heuckeroth et al., 1999), no cell
loss was found in GFRa2/ mice (Lindfors et al., 2006).
Since we do not observe loss of nonpeptidergic neurons
in Ret mutant DRGs, we speculate that the reduction of
GFRa2+ neurons reported for NRTN/ DRGs may not
be due to cell death. Instead, the deficit could be ex-
plained by a reduction in the level of GFRa2 expression.
To examine whether Ret signaling indeed regulates ex-
pression of GFRa2 or other GFRs, we assessed the ex-
pression of GFRs in Retf/f;Wnt1-Cre DRGs at both P2
and P10 by in situ hybridization (Figures 5 and S6). The
number of cells expressing GFRa1 and GFRa2 is signifi-
cantly reduced in Retf/f;Wnt1-Cremice (60% and 25% re-
duction for GFRa1 and GFRa2, respectively), suggesting
that expression of these coreceptors is controlled by Ret
signaling itself. Because there is a near-complete elimina-
tion of GFRa1 and GFRa2 expression in DRG neurons of
NGF/;Bax/ DRGs at P0 (Figures 2C–2F), these find-
ings suggest that NGF controls initial expression of
GFRa1 and GFRa2 and Ret signaling then autoregulates
expression of these GFR coreceptors.
Ret Signaling Controls Differentiation
of Nonpeptidergic DRG Neurons
One interesting possibility is that NGF-dependent expres-
sion of Ret and its GFR coreceptors enables a subset of
immature TrkA+ neurons to undergo GFL-dependent dif-
ferentiation and maturation. To determine whether Ret
signaling controls final stages of differentiation of nonpep-
tidergic nociceptors, we evaluated the expression of a
panel of genes that define the physiological properties of
nonpeptidergic neurons in DRGs from control and Retf/f;
Wnt1-Cre mice.
Trp class ion channels have been implicated as versatile
cell sensors in multiple sensory modalities, including noci-
ception and thermal sensation (Caterina, 2007). Expres-
sionofTrpA1 iscompletelyabsent inRetf/f;Wnt1-CreDRGs
at P14, while expression of TrpC3, TrpM8 and TrpV1 is un-
affected (Figures 6A–6H). The Mrg family includes more
than fifty G protein-coupled receptors (GPCRs), a dozen
of which are exclusively expressed in subsets of Ret+ non-
peptidergic sensory neurons (Dong et al., 2001). In P14
Retf/f;Wnt1-Cre DRGs, expression of MrgA1, MrgA3, and
MrgB4 is greatly reduced or absent, while expression of
MrgD is unperturbed compared to controls (Figures 6K–
6R). The expression of MrgB4 is normally initiated at P4,
and, in Ret mutant mice, expression of this gene wasNeuron 54, 739–754, June 7, 2007 ª2007 Elsevier Inc. 745
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Function of NGF and Ret in Nociceptor DevelopmentFigure 4. Peripheral and Central Projections of Peptidergic and Nonpeptidergic Neurons in Retf/f;MrgD-EGFP and Retf/f;Wnt1-
Cre;MrgD-EGFP Mice at P14
(A and B) Low-magnification view of glabrous skin innervation in Retf/f;MrgD-EGFP and Retf/f;Wnt1-Cre;MrgD-EGFP mice. Sections were immuno-
stained with anti-GFP (green) to visualize MrgD+ nonpeptidergic fibers and anti-CGRP (red) to visualize peptidergic fibers. Scale bar, 60 mm.
(C–H) High-magnification views of fibers in glabrous skin immunostained with CGRP (C and D), GFP (E and F), and merged (G and H). White arrows
point to intact CGRP+ fibers in both Retf/f;MrgD-EGFP and Retf/f;Wnt1-Cre;MrgD-EGFPmice (C and D). Note that GFP+ fibers were brightly stained
and abundant in the epidermis of control mice, whereas in Retf/f;Wnt1-Cre;MrgD-EGFPmice, these fibers were substantially reduced and appeared
punctate (white arrowheads point to remaining fibers). The white dotted line refers to the dermal-epidermal border (E and F). Scale bar, 30 mm.
(I and J) Central axonal projections in thoracic spinal cord sections show no difference in lamina specific innervation of peptidergic (red) and nonpep-
tidergic (green) projections of Retf/f;MrgD-EGFP and Retf/f;Wnt1-Cre;MrgD-EGFP mice . Scale bar, 10 mm.
(K) Quantification of the number of CGRP+ and GFP+ free nerve endings (FNE) crossing the dermal-epidermal border. Shown are the averages ± SEM
of eight to ten sections of two animals. Unit length is 300 mm of glabrous skin (see Supplemental Experimental Procedures). p < 0.05.
(L) Quantification of CGRP+ andGFP+ lamina thickness in the spinal cords ofRetf/f;MrgD-EGFP andRetf/f;Wnt1-Cre;MrgD-EGFPmice. Shown are the
averages ± SEM of eight to ten sections of two animals of each genotype.almost completely lost by P6 (Figure S7). This observation
is consistentwith the idea thatRet signaling is important for
initiation of expression ofMrgB4 rather than for its mainte-
nance. In contrast, expression of P2X3 in mutant DRGs is
similar to that of controls (Figures 6I and 6J). These results
indicate that Ret signaling controls expression of a subset
of genes characteristic of mature nonpeptidergic sensory
neurons.
Expression of TrpA1, TrpC3, TrpM8, TrpV1, MrgB4,
MrgD, and P2X3 is either reduced or eliminated in746 Neuron 54, 739–754, June 7, 2007 ª2007 Elsevier Inc.Runx1/ DRGs (Chen et al., 2006) and, as shown above,
expression of a subset of these genes is also lost in the ab-
sence of Ret signaling. We therefore asked whether the
phenotypes observed in Retf/f;Wnt1-Cremice are caused
by loss of expression of Runx1. To test this idea, expres-
sion of Runx1 in Retf/f;Wnt1-Cre and control DRGs was
assessed and found to be unaffected (Figures 6S and
6T). Consistent with this observation, Runx1 expression
begins at around E12.5, whereas Ret expression in non-
peptidergic neurons is initiated at E16. Therefore, Ret
Neuron
Function of NGF and Ret in Nociceptor Developmentfunctions downstream of Runx1, and loss of Ret expres-
sion in Runx1/ mice (Chen et al., 2006) likely accounts
for reduced expression of TrpA1 and MrgB4 in these
mutants.
Expression of Ret, Its Coreceptors, and Other
MarkerGenes Is Regulated byNGF, Possibly through
a Runx1-Dependent Pathway
A unique repertoire of genes is expressed in Ret+ nocicep-
tors, and our findings indicate that expression of a subset
of them is controlled by Ret signaling. It is noteworthy that
expression of many Ret-independent genes including
TrpM8 is initiated prior to expression of Ret (Chen et al.,
2006). These observations led us to ask whether extracel-
lular signals other than GFLs control expression of these
Ret-independent genes. Since many genes expressed in
nonpeptidergic nociceptors are regulated by Runx1, a re-
lated question is as follows: do extracellular cues promote
expression ofRunx1 enabling a subset of TrkA+ neurons to
adopt a nonpeptidergic neuronal fate? NGF stands out as
a candidate because its receptor TrkA is expressed as
early as E11.5, and NGF controls expression of Ret, which
Figure 5. Autoregulation of GFRs by Ret Signaling
(A–F) Expression of GFRa1 (Retf/f, 26 ± 2; Retf/f;Wnt1-Cre, 9 ± 2 posi-
tive neurons/section), GFRa2 (Retf/f, 78 ± 7; Retf/f;Wnt1-Cre, 50 ± 7
positive neurons/section), and GFRa3 (Retf/f, 41 ± 4; Retf/f;Wnt1-Cre,
36 ± 3 positive neurons/section) in DRGs at P10. Note that in addition
to a reduction in the number of cells expressing GFRa1 and GFRa2,
the level of expression ofGFRa1,GFRa2, but notGFRa3 in the remain-
ing neurons is lower in Retf/f;Wnt1-Cre mice. Shown are averages
±SEM from counts obtained from six to eight sections of three animals
of each genotype. Scale bar, 40 mm. Similar results were observed in
DRGs at P2 (Figure S6).is also controlled by Runx1 (Chen et al., 2006). To address
whether NGF controls expression of genes characteristic
of nonpeptidergic neurons and Runx1, we examined ex-
pression of TrpC3, TrpM8, TrpV1, MrgA1, MrgA3, MrgD,
P2X3, and Runx1 in both NGF/;Bax/ and NGF+/;
Bax/ control DRGs at P0 by in situ hybridization (Fig-
ure 7). Remarkably, expression of TrpC3, MrgA1, MrgA3,
and MrgD is completely eliminated (Figures 7A–7F, 7I,
and 7J) and TrpM8 is greatly reduced (Figures 7K and 7L)
inNGF/;Bax/DRGscompared toNGF+/;Bax/con-
trols. In contrast, expression of TrpV1 is only slightly re-
duced (Figures 7M and 7N), and expression of P2X3 is
unaffected (Figures7Gand7H) inNGF/;Bax/mutants.
Importantly, expression of Runx1 itself is dramatically
compromised in NGF/;Bax/ DRGs (Figures 7O and
7P) at P0. These results show thatRunx1 expression is un-
der the control of NGF. Interestingly, expression of Runx1
is unaffected in DRGs from NGF/;Bax/ mice at E14
(Figures 7Q and 7R), suggesting that NGF is not required
for initiation ofRunx1 expression but is critical for its main-
tenance. Since expression of most genes examined is not
initiated until late in development, it is therefore possible
that NGF controls expression of these genes through
a Runx1-dependent transcriptional pathway.
Ret Is Required for the Postnatal Extinction of TrkA
A critical, late event in maturation of Ret+ nonpeptidergic
nociceptors is the postnatal extinction of TrkA (Figure 1;
Molliver and Snider, 1997). Since expression of Ret pre-
cedes extinction of TrkA, we hypothesized that NGF-
dependent expression of Ret and its coreceptors enables
GFL-GFR/Ret signaling to instruct sensory neurons to ex-
tinguish TrkA. To address this possibility, we examined the
postnatal time course of TrkA extinction in control and
Retf/f;Wnt1-Cre mice. In our analysis of TrkA expression
from P0 to P14, we observed TrkA extinction in both con-
trol and mutant animals, but to different extents. At P0,
prior to the onset TrkA extinction, levels of TrkA expres-
sion in DRGs from both control and Retf/f;Wnt1-Cre mice
are indistinguishable (Figures 8A, 8B, and 8K). By P14,
however, the number of TrkA+ neurons had dramatically
decreased in control DRGs while, in contrast, the percent-
age of TrkA+ neurons remained significantly more ele-
vated in DRGs from Retf/f;Wnt1-Cre mice. This difference
is evident both at the mRNA and protein levels (Figures
8C–8F and 8K and data not shown). We reasoned that if
the increase in number of TrkA+ neurons in Retf/f;Wnt1-
Cre DRGs is due to a failure of immature nonpeptidergic
neurons to extinguish TrkA, then this deficit should be re-
flected by a higher proportion of cellular overlap between
TrkA and the nonpeptidergic neuronal marker IB4 and
a lower proportion of overlap between TrkA and the pep-
tidergic neuronal marker CGRP at P14. Indeed, although
only a few IB4+ neurons express TrkA in control P14
DRGs (9% ± 1.8%), the majority of IB4+ neurons (67% ±
9.1%) continue to express TrkA in Retf/f;Wnt1-Cre mice
(Figures 8G, 8H, and 8L). Conversely, coimmunostaining
with CGRP and TrkA revealed that nearly all TrkA+ neuronsNeuron 54, 739–754, June 7, 2007 ª2007 Elsevier Inc. 747
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Function of NGF and Ret in Nociceptor DevelopmentFigure 6. The Expression of Several Nonpeptidergic Neuron-Specific Genes Is Regulated by Ret Signaling
(A–H) Expression of TrpA1 (Retf/f, 7 ± 3; Retf/f;Wnt1-Cre, 0 positive neurons/section), TrpC3 (Retf/f, 50 ± 11; Retf/f;Wnt1-Cre, 52 ± 13 positive neurons/
section), TrpM8 (Retf/f, 18 ± 5; Retf/f;Wnt1-Cre, 16 ± 4 positive neurons/section), and TrpV1 (Retf/f, 52 ± 17; Retf/f;Wnt1-Cre, 45 ± 11 positive neurons/
section) in DRGs at P14. Note that expression of TrpA1 is completely absent in the mutant.
(I and J) Immunostaining of P2X3 (Retf/f, 105 ± 8; Retf/f;Wnt1-Cre, 110 ± 28 positive neurons/section).
(K–R) Expression of MrgA1 (Retf/f, 14 ± 3; Retf/f;Wnt1-Cre, 2 ± 1 positive neurons/section), MrgA3 (Retf/f, 10 ± 2; Retf/f;Wnt1-Cre, 2 ± 1 positive
neurons/section), MrgB4 (Retf/f, 52 ± 9; Retf/f;Wnt1-Cre, 2 ± 1 positive neurons/section), and MrgD (Retf/f, 45 ± 5; Retf/f;Wnt1-Cre, 59 ± 10 positive
neurons/section). Note that expression of MrgA1, MrgA3, and MrgB4 is greatly reduced in mutants.
(S and T) The number of Runx1-positive neurons is similar in mutant and control DRGs (Retf/f, 74 ± 15; Retf/f;Wnt1-Cre: 85 ± 12 positive neurons/sec-
tion). Scale bar, 40 mm.coexpress CGRP in control DRGs, whereas numerous
small-diameter TrkA+ cells do not coexpress CGRP in
Retf/f;Wnt1-Cre DRGs (Figures 8I, 8J, and 8L). These find-
ings demonstrate that the increase in the percentage of
TrkA+ neurons found in postnatal Retf/f;Wnt1-Cre mice is
a consequence of the failure of immature Ret+/TrkA+ non-
peptidergic neurons to extinguish TrkA. Since TrkA extinc-
tion still partially occurs in the absence of Ret signaling,
other signals must also play a role in this process. Never-
theless, NGF-dependent expression of Ret signaling is an
important step in the postnatal extinction of TrkA, a late
event in thematurationof nonpeptidergic sensory neurons.748 Neuron 54, 739–754, June 7, 2007 ª2007 Elsevier Inc.DISCUSSION
Here, we show that NGF-dependent expression of the Ret
receptor tyrosine kinase is required for diversification,
maturation, and peripheral innervation of nonpeptidergic
DRG sensory neurons. NGF controls expression of Ret
and its coreceptors GFRa1 and GFRa2. Ret signaling, in
turn, regulates expression of both GFRa1 and GFRa2
and promotes expression of ion channels and receptors,
acquisition of normal neuronal size, innervation of the epi-
dermis, and extinction of TrkA. Moreover, NGF controls
expression of other genes characteristic of nonpeptidergic
Neuron
Function of NGF and Ret in Nociceptor DevelopmentFigure 7. NGF Controls Expression of a Large Number of Nonpeptidergic Neuron-Specific Genes
(A–F) Expression of MrgA1 (NGF+/;Bax/, 17 ± 5; NGF/;Bax/, 0 positive neurons/section), MrgA3 (NGF+/;Bax/, 16 ± 6; NGF/;Bax/,
0 positive neurons/section), and MrgD (NGF+/;Bax/, 62 ± 9; NGF/;Bax/, 0 positive neurons/section) in DRGs at P0.
(G and H) Expression of P2X3 (NGF+/;Bax/, 176 ± 47; NGF/;Bax/, 177 ± 37 positive neurons/section) in DRGs at P0.
(I–N) Expression of TrpC3 (NGF+/;Bax/, 31 ± 6; NGF/;Bax/, 0 positive neurons/section), TrpM8 (NGF+/;Bax/, 31 ± 3; NGF/;Bax/, 4 ± 1
positive neurons/section), and TrpV1 (NGF+/;Bax/, 59 ± 12; NGF/;Bax/, 40 ± 14 positive neurons/section) in DRGs at P0.
(O and P) Expression of Runx1 (NGF+/;Bax/, 184 ± 13; NGF/;Bax/, 62 ± 10 positive neurons/section) in DRGs at P0.
(Q and R) Expression of Runx1 (NGF+/;Bax/, 180 ± 16; NGF/;Bax/, 185 ± 15 positive neurons/section) in DRGs at E14. Similar results were
found in six to eight sections from two animals of each genotype. Scale bar, 40 mm.neurons, including Runx1, through a Ret-independent
signaling pathway. We propose a model in which NGF
instructs maturation of nonpeptidergic DRG neurons
through a combination of GFR/Ret-dependent and inde-
pendent signaling pathways (Figure 9).
Ret Signaling Controls Cell Size but Not Survival
of Nonpeptidergic Neurons
Whether GFL-GFR/Ret signaling is required for survival of
DRG neurons has been a controversial issue. There is
a plethora of data supporting the idea that GFLs can sup-
port postnatal survival of DRG neurons in vitro (Adler,1998; Forgie et al., 1999; Matheson et al., 1997; Molliver
et al., 1997). However, of all the GFL and GFR mutant
mice examined, only the GDNF and NRTN mutants are
reported to exhibit a significant loss of DRG neurons
(Heuckeroth et al., 1999; Moore et al., 1996). Our findings
show that Ret signaling is dispensable for viability of non-
peptidergic DRG neurons in vivo. This conclusion is based
on the following observations: (1) the number of Runx1+
neurons, which are destined to become nonpeptidergic
neurons, is identical in Retf/f;Wnt1-Cre and Retf/f DRGs;
(2) the number of neurons expressing P2X3, a marker of
nonpeptidergic neurons, is virtually identical in Retf/f;Neuron 54, 739–754, June 7, 2007 ª2007 Elsevier Inc. 749
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Function of NGF and Ret in Nociceptor DevelopmentFigure 8. Ret Signaling Is Required for Postnatal Extinction of TrkA
(A–F) Immunostaining for TrkA in DRGs fromRetf/f and Retf/f;Wnt1-Cremice at P0 (A and B), P10 (C and D), and P14 (E and F) (n = 3). Scale bar, 40 mm.
(G and H) Double labeling with TrkA immunohistochemistry and IB4 binding at P14 in Retf/f and Retf/f;Wnt1-Cre mouse DRGs. Arrows indicate the
TrkA+/IB4+ neurons in Retf/f;Wnt1-Cre DRGs, which are smaller and weakly labeling with IB4 compared to control animals.
(I and J) Double immunostaining with TrkA and CGRP at P14. Arrows indicate the TrkA+/CGRP neurons inRetf/f;Wnt1-CreDRGs, which are probably
hypotrophic nonpeptidergic neurons that failed to extinguish TrkA. Scale bar, 20 mm.
(K) Quantification of TrkA extinction in DRG neurons inRetf/f and Retf/f;Wnt1-Cremice as a function of age. Shown is the percentage of TrkA+ neurons
per DRG (TrkA+ neurons/PGP9.5+ neurons) in Retf/f and Retf/f;Wnt1-Cremice at P0 (78.5% ± 8.9% versus 75.7% ± 4.0%), P10 (49.0% ± 4.9% versus
68.2% ± 4.4%), and P14 (30.5% ± 2.2% versus 55.4% ± 7.1%). Note that although there is some TrkA extinction in Retf/f;Wnt1-Cre DRGs from P0 to
P14 (p < 0.001), it is significantly less compared to that of Retf/f mice at both P10 and P14 (**p < 0.001; n = 3 for each condition).
(L) Ratios of TrkA+;CGRP– neurons/CGRP+ neurons (24.5% ± 2.2% versus 99.8% ± 2.5%) and TrkA+;IB4+ neurons/IB4+ neurons (9% ± 1.8% versus
67.3% ± 9.1%) in Retf/f and Retf/f;Wnt1-Cre DRGs at P14 (**p < 0.001).
Shown are means ± SEM.Wnt1-Cre and control DRGs; (3) no active caspase-3-pos-
itive neurons are observed in postnatal Retf/f;Wnt1-Cre
DRGs; (4) counts of dissociated DRG neurons from mu-
tant and control L5 DRGs reveal similar neuronal numbers;
(5) the ratios of peptidergic, nonpeptidergic, and mecha-750 Neuron 54, 739–754, June 7, 2007 ª2007 Elsevier Inc.nosensory DRG neurons are comparable in mutant and
control DRGs. We are unable to make a conclusion about
the role of Ret signaling in the viability of the early Ret+
population, however, because of the lack of reliable
markers to identify these neurons. Nevertheless, our
Neuron
Function of NGF and Ret in Nociceptor Developmentfindings show that Ret signaling is not required for viability
of nonpeptidergic neurons but is critical for acquisition of
normal neuronal size.
Which GFRs and GFLs Interact with Ret
in Nonpeptidergic Neurons?
Which are the relevant GFL-GFR interaction(s) that acti-
vate(s) Ret signaling during development of nonpeptider-
gic neurons? We found that Retf/f;Wnt1-Cre mice exhibit
some similarities to GFRa2/mice (Lindfors et al., 2006).
For example, both Retf/f;Wnt1-Cre and GFRa2/ mice
display hypotrophic nonpeptidergic neurons and periph-
eral target innervation defects. These findings are in
agreement with our observation that GFRa2 is the pre-
dominant GFR expressed in DRG neurons. Thus, GFRa2
appears to be the main coreceptor of Ret in nonpeptider-
gic neurons. NRTN is likely to be a primary ligand for the
GFRa2/Ret receptor complex on axons of nonpeptidergic
neurons because it is highly expressed in skin starting at
E14 (Golden et al., 1999) and has the highest affinity for
GFRa2 in vitro. Moreover, GFRa2+ neurons are hypotro-
phic in DRGs of NRTN/ mice (Heuckeroth et al., 1999).
Figure 9. A Model of Development of a Nonpeptidergic
Neuron
NGF, Runx1, and Ret function hierarchically to instruct molecular and
physiological diversification and maturation of nonpeptidergic DRG
sensory neurons. The mechanism of initiation of expression of Runx1
is unclear but likely involves an intrinsic transcriptional mechanism.
NGF is critical for the maintenance of Runx1 expression in cells des-
tined to become nonpeptidergic neurons. Runx1, in turn, controls ex-
pression of genes characteristic of nonpeptidergic neurons through
both Ret-dependent and Ret-independent pathways. The arrows in
this model depict the developmental progression of events for non-
peptidergic neurons, whichmight include several steps. Red and black
lines indicate positive and negative regulation, respectively. Yellow
lines do not imply positive or negative regulation but show the overall
convergence of events that lead to the final, mature nonpeptidergic
neuron.Despite these similarities, we cannot exclude the possibil-
ity that GDNF or ARTN is responsible for some of pheno-
types observed in the Ret mutants, in part due to the pro-
miscuity of GFL/GFR interactions. Further examination of
mice lacking theGFLs andGFRs and a closer comparison
ofGFL,GFR, andRetmutant mice should improve our un-
derstanding of the physiologic pairing of GFLs and GFR/
Ret complexes in DRG neurons in vivo.
Ret Signaling Is Required for Expression of Several
Ion Channels and GPCRs in Nonpeptidergic Neurons
The transcription factor Runx1 plays an essential role in
the differentiation of nonpeptidergic neurons (Chen et al.,
2006). In Runx1/ DRGs, immature TrkA+ sensory neu-
rons fail to adopt a nonpeptidergic neuronal phenotype
and instead acquire characteristics of peptidergic cutane-
ous neurons. The authors of that study contend that
regulation of many nociceptive ion channels is Runx1 de-
pendent but Ret signaling independent, based on the ob-
servation that expression of a Runx1-dependent gene,
TrpM8, is initiated prior to Ret in DRG neurons. Our results
withRetf/f;Wnt1-Cremice show this to be true. Indeed, ex-
pression of TrpM8, TrpC3, TrpV1, MrgD, and P2X3 is un-
changed in Ret mutants. However, our work also shows
that expression of several other nonpeptidergic neuron-
specific genes is strictly dependent upon Ret signaling.
Expression of TrpA1, MrgA1,MrgA3, andMrgB4 is either
completely eliminated or greatly reduced in Retf/f;Wnt1-
Cre DRGs. Consistent with these findings, artemin over-
expression in mouse skin enhances expression of TrpA1
in DRG neurons (Elitt et al., 2006). Taken together, our
results show that there are both Runx1-dependent/
Ret-independent and Runx1-dependent/Ret-dependent
pathways that control gene expression events in nonpep-
tidergic neurons. We speculate that these two pathways
work in a sequential manner: the Runx1-dependent/Ret-
independent pathway functions between E13 to P0 to
control expression of TrpC3, TrpM8, TrpV1, MrgD, and
P2X3 and innervation of the proper dorsal lamina of the
spinal cord. The Runx1-dependent/Ret-dependent path-
way, in contrast, functions from E16 and beyond to regu-
late expression of TrpA1, MrgA1, MrgA3, and MrgB4,
acquisition of normal neuronal size, skin innervation, and
extinction of TrkA (Figure 9).
NGF Regulates Expression of Runx1, GFRs, and Ret
Runx1 is required for expression of nearly all genes char-
acteristic of nonpeptidergic neurons. Interestingly, while
expression of Runx1 is unaffected in NGF/;Bax/
mice at E14, it is substantially reduced at P0. Expression
of Runx1 is virtually unaffected in DRGs lackingRet. These
findings, taken together, suggest that NGF controls main-
tenance of Runx1 expression, which, in turn, is likely to
support expression of Ret, the GFRs, and a large cohort
of genes characteristic of nonpeptidergic neurons. In ad-
dition, NGF may control the expression or activity of other
factors that are required for efficient Runx1-dependent
transcription, perhaps including Runx1 transcriptionalNeuron 54, 739–754, June 7, 2007 ª2007 Elsevier Inc. 751
Neuron
Function of NGF and Ret in Nociceptor Developmentcoactivators or inhibitors. Thus, genes expressed in non-
peptidergic neurons fall into one of three categories based
on the control of their expression: there is an NGF-depen-
dent, Runx1-dependent, and Ret-independent subclass
(TRPM8, TRPC3, MrgD, and TrpV1); an NGF-dependent,
Runx1-dependent, and Ret-dependent subclass (TRPA1,
MrgA1, MrgA3, and MrgB4); and a third subclass of
NGF-independent, Runx1-dependent genes (P2X3 and
TRPV1). However, data supporting the notion of this third
class of genes aremore equivocal. One confounding point
is that expression of neither TRPV1 nor P2X3 is exclusive
to nonpeptidergic neurons. Also, there is only a 50% loss
of P2X3+ neurons, and expression of TRPV1 is reduced
only in a subset of neurons in Runx1/ mice (Chen
et al., 2006). These observations imply that if Runx1 is
partially lost, as we observed in DRGs from P0 NGF/;
Bax/ mice, then expression of TRPV1 and P2X3 should
be modestly affected. Nevertheless, our findings indicate
that target-derived NGF controls both Ret-dependent and
Ret-independent steps in the maturation of nonpeptider-
gic neurons and that NGF signals are mediated, at least
in part, through maintenance of Runx1 expression.
The development of nonpeptidergic neurons involves
a two step process consisting of Ret expression in TrkA+
precursors, followed by postnatal extinction of TrkA in
Ret+/TrkA+ neurons. It is interesting that NGF controls
the initial expression of GFRs and Ret, indicating that the
GFR/Ret holoreceptor complex is synthesized in DRG
neurons upon innervation of target fields and the acquisi-
tion of target-derived NGF. We further demonstrate that
Ret signaling controls the postnatal extinction of TrkA.
This indicates that, through the functions of Ret, NGF sup-
presses the expression of its own receptor thereby ren-
dering Ret+ neurons insensitive to further NGF influence.
What is the importance of hierarchical control of neuro-
trophic factor signaling during nonpeptidergic sensory
neuron development? One idea stems from the observa-
tion that multiple populations of neurons use the same
neurotrophic growth factor for axonal growth and target
innervation. GDNF, for example, is required at branch
points in the limbs, including the brachial plexus and in
muscle tissue, to guide motor neurons to their final targets
(Kramer et al., 2006a). Although axons of developing cuta-
neous sensory neurons and spinal motor neurons share
common initial, proximal trajectories, they diverge at their
distal trajectories to innervate skin and skeletal muscle,
respectively. Thus, if cutaneous sensory neurons prema-
turely express GFR/Ret holoreceptors, they may be inap-
propriately influenced by proximal growth and guidance
cues, such asGDNF in the brachial plexus. AnNGF-induc-
ible Ret and GFR expression paradigm ensures that sen-
sory neurons remain unresponsive to GFLs en route to
their specific target fields but gain sensitivity to target-de-
rived GFLs only after divergence from motor neuron pro-
jections. Thus, through their actions at intermediate and
final targets, a limited repertoire of neurotrophic factors
can be employed by axons of disparate sets of developing
neurons.752 Neuron 54, 739–754, June 7, 2007 ª2007 Elsevier Inc.EXPERIMENTAL PROCEDURES
Generation of Retf/f;Wnt1-Cre and NGF/;Bax/ Mice
The Ret targeting vector was constructed using a BAC clone isolated
from a 129Jmouse genomic library (RPCI-22). The 7.4 kb Hind III-Age I
fragment spanning exons 7 through 13 ofRetwas used as the long arm
and the 0.8 kb Hind III-Hind III in intron 15 as the short arm. The 1.4 kb
Age I-Hind III fragment containing exons 14 and 15 served as the tar-
geted sequence. In addition, a single nucleotide missense mutation
was introduced to change valine 805 to alanine. This mutation is func-
tionally silent but does sensitize the resulting protein to chemical inhi-
bition of its kinase activity (data not shown). The targeted sequence
was placed upstream of an FRT-Neo-FRT selection cassette, and
the resulting sequence was flanked by loxP sites. The targeting con-
struct was linearized and electroporated into 129.1 mouse embryonic
stem cells. Resulting clones were selected with G418 (300 mg/ml),
screened by PCR, and verified with Southern blotting using both inter-
nal and external probes. Four confirmed clones were injected into
blastocyst. Three germline-transmitting chimeric animals were identi-
fied after crossing to C57BL/6 mice. These mice were mated to a
mouse strain expressing Cre recombinase under the control of the
Wnt1 promoter (a generous gift from Dr. Henry Sucov, University of
Southern California). NGF/;Bax/ mice were generated as previ-
ously described (Glebova and Ginty, 2004). MrgD-EGFP mice were
kindly provided by Dr. David Anderson (Caltech) and Dr. Xinzhong
Dong (Johns Hopkins University).
In Situ Hybridization and Immunohistochemistry
Digoxigenin (DIG)-labeled cRNA probes were used for in situ hybrid-
ization. In situ hybridization probes directed against GFRa1, GFRa2,
GFRa3, Runx1, and TrkA were amplified with gene specific sets of
PCR primers and cDNA templates prepared from E14.5 mouse
DRG. Probes for TRPA1, TRPV1, TRPC3, and TRPM8 were a kind
gift from Dr. David Corey (Harvard Medical School). In situ probes for
MrgA1, MrgA3, MrgD, MrgB4, P2X3, and Ret were kindly provided
by Dr. Xinzhong Dong (Johns Hopkins University). Double-fluorescent
in situ hybridization was performed using a combination of DIG-la-
beled and fluorescein-labeled cRNA probes as previously described
(Dong et al., 2001).
For immunohistochemistry on frozen DRG sections, the antibodies
used in this study were as follows: rabbit anti-TrkA (a gift from Dr Louis
Reichardt, University of California, San Francisco, 1:1000), rabbit
(Chemicon, 1:2000) ormouse anti-peripherin (Chemicon, 1:500), rabbit
anti-CGRP (Chemicon, 1:1000), rabbit anti-PGP9.5 (Chemicon,
1:1000), rabbit anti-P2X3 (Chemicon, 1:1000), and mouse anti-Neuro-
filament-200 (Sigma, 1:500). Secondary antibody incubations were
performed with Alexafluor-546 or Alexafluor-488 conjugated second-
ary antibodies (Molecular Probes, 1:500). For immunostaining with
hindpaw glabrous skin to visualize the epidermal innervation, we fol-
lowed the protocol as described (Zylka et al., 2005).
Supplemental Data
The Supplemental Data for this article can be found online at http://
www.neuron.org/cgi/content/full/54/5/739/DC1/.
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